ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against Anavex Life Sciences Corp. (NASDAQ: AVXL) in the U.S. District Court for the Southern District of New York. The complaint alleges that the company and its executives violated federal securities laws by making false and misleading statements regarding adequate internal controls, understating regulatory challenges related to misconduct by former CEO Christopher Missling, and misrepresenting the company's business and prospects. Investors who purchased Anavex securities between November 26, 2025 and August 28, 2026 may be eligible to participate in the lawsuit.